ESCMID eLibrary

Search results
Icon explanation








-
P1833
Outer membrane permeability of 15 beta-lactams in multidrug-resistant Acinetobacter baumannii (MDR-AB) characterised via LC-MS/MS
15 April 2019
Session: Screening for antimicrobial pharmacological properties
-
P1834
Comprehensive thermal stability data and optimal supplement dosing schemes for in vitro time-kill experiments with 10 beta-lactams and 3 beta-lactamase inhibitor in Mueller-Hinton broth
15 April 2019
Session: Screening for antimicrobial pharmacological properties
-
P1956
Population pharmacokinetics of the new oxazolidinone prodrug contezolid acefosamil (MRX-4) and its metabolites after single and multiple ascending intravenous doses in healthy volunteers
15 April 2019
Session: Recent research on the pharmacokinetics and safety of antibacterial agents
-
P1948
First simultaneous population pharmacokinetic characterisation of a beta-lactam/beta-lactamase inhibitor combination: gastrointestinal transit and absorption kinetics of amoxicillin/clavulanic acid
15 April 2019
Session: Recent research on the pharmacokinetics and safety of antibacterial agents
-
P1532
Novel cassette assay to simultaneously characterize the outer membrane permeability of five beta-lactams in Klebsiella pneumoniae carbapenemase-producing K.pneumoniae (KPC-KP)
23 April 2018
Session: Exploring antibacterial activity with the help of pharmacology
-
P1531
First comprehensive penicillin-binding protein (PBP) occupancy patterns of beta-lactams in Acinetobacter baumannii (AB)
23 April 2018
Session: Exploring antibacterial activity with the help of pharmacology
-
P1530
First data on Penicillin-binding protein (PBP) occupancy patterns of beta-lactams in Klebsiella pneumoniae (KP)
23 April 2018
Session: Exploring antibacterial activity with the help of pharmacology
-
O0579
Extensive, synergistic killing of polymyxin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) by beta-lactam plus amikacin combinations
22 April 2018
Session: Drug combinations: pre-clinical evidence
-
P0262
Imipenem kills Pseudomonas aeruginosa (PA) substantially faster than meropenem and doripenem most likely due to more rapid outer-membrane (OM) penetration
21 April 2018
Session: Pre-clinical PK/PD
Search narrowed by
-
Topics
-
Type of material
-
Time period